Takeda Pharmaceutical Long-Term Investments 2010-2024 | TAK

Takeda Pharmaceutical long-term investments for the quarter ending September 30, 2024 were $2.862B, a 0.38% decline year-over-year.

  • Takeda Pharmaceutical long-term investments for 2024 were $2.971B, a 5.98% increase from 2023.
  • Takeda Pharmaceutical long-term investments for 2023 were $2.804B, a 4.58% decline from 2022.
  • Takeda Pharmaceutical long-term investments for 2022 were $2.938B, a 10.27% decline from 2021.

Takeda Pharmaceutical Long-Term Investments 2010-2024 | TAK

  • Takeda Pharmaceutical long-term investments for 2024 were $2.971B, a 5.98% increase from 2023.
  • Takeda Pharmaceutical long-term investments for 2023 were $2.804B, a 4.58% decline from 2022.
  • Takeda Pharmaceutical long-term investments for 2022 were $2.938B, a 10.27% decline from 2021.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$79.7B
Sandoz Group AG (SDZNY)$19.3B
Merck (MKKGY)$18.8B
Astellas Pharma (ALPMY)$18.3B
United Therapeutics (UTHR)$16.4B
Summit Therapeutics (SMMT)$13.6B
Neurocrine Biosciences (NBIX)$12.7B
Shionogi (SGIOY)$11.8B
Catalent (CTLT)$10.8B
Jazz Pharmaceuticals (JAZZ)$7.6B
Madrigal Pharmaceuticals (MDGL)$7.2B
Orion OYJ (ORINY)$6.7B
Corcept Therapeutics (CORT)$5.9B
Ionis Pharmaceuticals (IONS)$5.4B
Crinetics Pharmaceuticals (CRNX)$5.3B
PTC Therapeutics (PTCT)$3.3B
Dyne Therapeutics (DYN)$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
Soleno Therapeutics (SLNO)$2.4B
Arrowhead Pharmaceuticals (ARWR)$2.3B
Centessa Pharmaceuticals (CNTA)$2.1B
Evotec AG (EVO)$1.9B
NewAmsterdam Pharma (NAMS)$1.9B
Xencor (XNCR)$1.7B
Recursion Pharmaceuticals (RXRX)$1.6B
Harrow (HROW)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.6B
Cassava Sciences (SAVA)$1.5B
Indivior (INDV)$1.5B